Prudential Financial Inc. Reduces Position in Exponent, Inc. (NASDAQ:EXPO)

Prudential Financial Inc. decreased its holdings in Exponent, Inc. (NASDAQ:EXPO) by 64.2% in the fourth quarter, Holdings Channel reports. The fund owned 5,048 shares of the business services provider’s stock after selling 9,042 shares during the period. Prudential Financial Inc.’s holdings in Exponent were worth $450,000 at the end of the most recent reporting period.

A number of other institutional investors have also bought and sold shares of EXPO. Raymond James Financial Inc. purchased a new position in shares of Exponent during the 4th quarter worth $55,131,000. JPMorgan Chase & Co. grew its holdings in shares of Exponent by 63.6% in the third quarter. JPMorgan Chase & Co. now owns 630,644 shares of the business services provider’s stock valued at $72,701,000 after purchasing an additional 245,086 shares during the period. Geode Capital Management LLC increased its position in Exponent by 4.8% during the third quarter. Geode Capital Management LLC now owns 1,505,652 shares of the business services provider’s stock worth $173,597,000 after purchasing an additional 69,099 shares during the last quarter. Vanguard Group Inc. raised its stake in Exponent by 1.3% during the fourth quarter. Vanguard Group Inc. now owns 5,345,503 shares of the business services provider’s stock worth $476,284,000 after purchasing an additional 67,296 shares during the period. Finally, Barclays PLC boosted its holdings in Exponent by 219.0% in the 3rd quarter. Barclays PLC now owns 96,526 shares of the business services provider’s stock valued at $11,127,000 after purchasing an additional 66,263 shares during the last quarter. 92.37% of the stock is owned by hedge funds and other institutional investors.

Exponent Price Performance

Shares of NASDAQ EXPO opened at $79.79 on Thursday. The company has a market capitalization of $4.05 billion, a P/E ratio of 37.64 and a beta of 0.84. The company has a 50 day simple moving average of $84.02 and a 200-day simple moving average of $93.72. Exponent, Inc. has a 1 year low of $73.83 and a 1 year high of $115.75.

Exponent (NASDAQ:EXPO) last posted its earnings results on Thursday, February 6th. The business services provider reported $0.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.06. Exponent had a return on equity of 27.27% and a net margin of 19.52%. During the same quarter in the previous year, the business earned $0.41 earnings per share. As a group, research analysts expect that Exponent, Inc. will post 1.98 EPS for the current year.

Insider Activity at Exponent

In other Exponent news, VP Richard Reiss sold 1,736 shares of Exponent stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $85.93, for a total transaction of $149,174.48. Following the completion of the sale, the vice president now directly owns 1,800 shares in the company, valued at $154,674. This trade represents a 49.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 2.10% of the stock is owned by insiders.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.